Citations

Clear

13574 citation(s) found for "_, _".

The stimulant action of acetylcholine and catecholamines on the uterus
Szurszewski, Joseph H., Bülbring, Edith

Mayo Clinic

Philosophical Transactions of the Royal Society of London. B, Biological Sciences | December 15, 2006 | Volume: 265 | Issue: 867 | Pages: 149-156

10.1098/rstb.1973.0017 | PMID 4144683 Get It

Abstract The α action of catecholamines on oestrogen dominated guinea-pig uterus is stimulant. The cell membrane is depolarized, membrane conductance is increased, spike discharge is accelerated and tension develops. This action resembles that of acetylcholine though catecholamines are less potent, and, in equiactive concentrations, catecholamines have a longer latency and a longer duration of action. Evidence, obtained by modifications of the ionic environment, indicates that the depolarization by acetylcholine is due to an increase in sodium and calcium permeability and that acetylcholine can release calcium from intracellular stores. The depolarization by catecholamines is due to an increase in chloride permeability and, in addition, sodium is required for the ensuing increase of spike discharge. Catecholamines produce an increase in the force of contraction, long outlasting their immediate stimulation. Moreover, their effect on membrane potential and membrane conductance persists in the presence of lanthanum. These results suggest that Ca release from intracellular stores may be the primary effect produced by the α action of catecholamines and that the increase in the cytoplasmic Ca2+ concentration may cause the changes at the cell membrane.
Taking Steps Toward Integration
Cortese, Denis A., Smoldt, Robert K.

Mayo Clinic

Health Affairs | December 6, 2006 | Volume: 25 | Issue: Suppl1 | Pages: W68-W71

10.1377/hlthaff.26.1.w68 | PMID 17148492 Get It

The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota
Pardi, Darrell S. , Loftus, Edward V. , Smyrk, Thomas C. , Kammer, Patricia P., Tremaine, William J., Schleck, C. D., Harmsen, William S. , Zinsmeister, Alan R., Melton, L. Joseph, Sandborn, William J. , Loftus, Edward V

Mayo Clinic

Gut | November 29, 2006 | Volume: 56 | Issue: 4 | Pages: 504-508

10.1136/gut.2006.105890 | PMID 17135309 Get It

Objective: Although the epidemiology of microscopic colitis has been described in Europe, no such data exist from North America. We studied the incidence, prevalence and temporal trends of microscopic colitis in a geographically defined US population. Design and setting: In this population based cohort study, residents of Olmsted County, Minnesota, with a new diagnosis of microscopic colitis, and all who had colon biopsies for evaluation of diarrhoea, between 1 January 1985 and 31 December 2001 were identified. Biopsies were reviewed for confirmation (cases) and to identify missed cases (diarrhoea biopsies). Main outcome measures: Incidence rates, age and sex adjusted to the 2000 US white population. Poisson regression assessed the association of calendar period, age and sex with incidence. Results: We identified 130 incident cases for an overall rate of 8.6 cases per 100 000 person-years. There was a significant secular trend, with incidence increasing from 1.1 per 100 000 early in the study to 19.6 per 100 000 by the end (p<0.001). Rates increased with age (p<0.001). By subtype, the incidence was 3.1 per 100 000 for collagenous colitis and 5.5 per 100 000 for lymphocytic colitis. Collagenous colitis was associated with female sex (p<0.001) but lymphocytic colitis was not. Prevalence (per 100 000 persons) on 31 December 2001 was 103.0 (39.3 for collagenous colitis and 63.7 for lymphocytic colitis). Conclusions: The incidence of microscopic colitis has increased significantly over time, and by the end of the study, the incidence and prevalence were significantly higher than reported previously. Microscopic colitis is associated with older age, and collagenous colitis is associated with female sex.
Plasma lipids and fatty acids in urbanized Bushmen, Hereros and Kavangos of Southern Africa (Namibia)
Tichelaar, H.Y., Benadé, A. J. S., O’Keefe, Stephen J. , Jooste, P. L., Swanevelder, Sonja , Staden, E. Van

Mayo Clinic

Lipids | November 29, 2006 | Volume: 27 | Issue: 9 | Pages: 729-732

10.1007/bf02536033 | PMID 1487973 Get It

AbstractThirty‐nine urbanized ethnic Namibian people comprising 21 Bushmen (semi‐urbanized), 7 Hereros and 11 Kavangos were assessed for plasma lipids and fatty acid (FA) composition. Total cholesterol and triacylglycerol concentrations were measured by enzymatic methods, and neutral lipid FA composition by gas‐liquid chromatography. The results demonstrated that while total cholesterol concentrations were not significantly different, significant differences in triacylglycerol concentrations (P<0.05) were seen between Bushmen and Kavangos. By comparing Bushmen with Hereros and Kavangos, significant differences between Bushmen and Kavangos were also observed in plasma triacylglycerol FA compositions, particularly 16∶0 (32.73%vs. 25.05%), 16∶1n−7 (7.00%vs. 5.06%), 18∶2n−6 (9.30%vs. 22.25%) and 20∶3n−6 (0.12%vs. 0.48%), while Kavangos had higher 20∶4n−6 levels than Hereros (1.44%vs. 2.00%). In plasma cholesteryl esters, Bushmen were significantly different from Kavangos in 16∶1n−7 (8.85%vs. 4.93%), 18∶1n−9 (32.06%vs. 23.07%) and 20∶4n−6 (6.91%vs. 10.00%). Significant differences were also observed between Bushmen and Hereros in 18∶0 (1.08%vs. 1.29%) and 18∶2n−6 (35.68%vs. 45.50%). The FA of Namibian groups were also compared with South African reference groups comprising urbanized whites and Xhosas and rural Vendas. The differences in blood lipid values can be explained primarily by excessive alcohol consumption. These results suggest that semi‐urbanized Bushmen have changed their diets under urbanized conditions which may increase their risk of coronary heart disease.
Skeletal Muscle Mitochondrial Functions, Mitochondrial DNA Copy Numbers, and Gene Transcript Profiles in Type 2 Diabetic and Nondiabetic Subjects at Equal Levels of Low or High Insulin and Euglycemia
Asmann, Yan W. , Stump, Craig S., Short, Kevin R. , Coenen-Schimke, Jill M., Guo, ZengKui, Bigelow, Maureen L., Nair, K. Sreekumaran

Mayo Clinic

Diabetes | November 27, 2006 | Volume: 55 | Issue: 12 | Pages: 3309-3319

10.2337/db05-1230 | PMID 17130474 Get It

We investigated whether previously reported muscle mitochondrial dysfunction and altered gene transcript levels in type 2 diabetes might be secondary to abnormal blood glucose and insulin levels rather than an intrinsic defect of type 2 diabetes. A total of 13 type 2 diabetic and 17 nondiabetic subjects were studied on two separate occasions while maintaining similar insulin and glucose levels in both groups by 7-h infusions of somatostatin, low- or high-dose insulin (0.25 and 1.5 mU/kg of fat-free mass per min, respectively), and glucose. Muscle mitochondrial DNA abundance was not different between type 2 diabetic and nondiabetic subjects at both insulin levels, but the majority of transcripts in muscle that are involved mitochondrial functions were expressed at lower levels in type 2 diabetes at low levels of insulin. However, several gene transcripts that are specifically involved in the electron transport chain were expressed at higher levels in type 2 diabetic patients. After the low-dose insulin infusion, which achieved postabsorptive insulin levels, the muscle mitochondrial ATP production rate (MAPR) was not different between type 2 diabetic and nondiabetic subjects. However, increasing insulin to postprandial levels increased the MAPR in nondiabetic subjects but not in type 2 diabetic patients. The lack of MAPR increment in response to high-dose insulin in type 2 diabetic patients occurred in association with reduced glucose disposal and expression of peroxisome proliferator–activated receptor-γ coactivator 1α, citrate synthase, and cytochrome c oxidase I. In conclusion, the current data supports that muscle mitochondrial dysfunction in type 2 diabetes is not an intrinsic defect, but instead a functional defect related to impaired response to insulin.
Differences in the phospholipid, cholesterol, and fatty acyl composition of 3T3 and SV3T3 plasma membranes
Perkins, Roger, Scott, Robert E.

Mayo Clinic

Lipids | November 22, 2006 | Volume: 13 | Issue: 10 | Pages: 653-657

10.1007/bf02533741 | PMID 214660 Get It

AbstractAn analysis of the phospholipid, cholesterol, and phospholipid fatty acyl composition of isolated plasma membranes of 3T3 and SV3T3 mouse embryo cells has been performed. The results show that the plasma membrane of SV3T3 cells contain relatively less phosphatidylethanolamine and sphingomyelin and more cholesterol than 3T3 plasma membranes. The fatty acyl composition of individual phospholipid classes as determined by gas liquid chromatography also showed differences between 3T3 and SV3T3 plasma membranes. The plasma membranes of SV40 transformed 3T3 cells contain: (a) a higher percentage of 18∶1 and less 20∶3 and 20∶4 in phosphatidylethanolamine; (b) a higher percentage of 18∶1 in phosphatidylserine; and (c) a higher percentage of 18∶2 and 20∶4 in phosphatidylinositol.
Plasma membrane phospholipid, cholesterol and fatty acyl composition of differentiated and undifferentiated L6 myoblasts
Perkins, Roger, Scott, Robert E.

Mayo Clinic

Lipids | November 22, 2006 | Volume: 13 | Issue: 5 | Pages: 334-337

10.1007/bf02533724 | PMID 672469 Get It

AbstractThe lipid composition of plasma membranes isolated from differentialted and undifferentiated L6 myoblasts has been compared. In general, the plasma membranes of differentiated L6 myoblasts have a higher cholesterol to phospholipid molar ratio than plasma membranes of undifferentiated cells. Differentiated L6 myoblasts have increased relative amounts of phosphatidylethanolamine and phosphatidylcholine in their plasma membrane and a decreased relative amount of sphingomyelin when compared with the plasma membranes of undifferentiated myoblasts. In addition, preliminary results show that differentiated L6 myoblasts plasma membrane phospholipid shows differences in the fatty acyl composition, specifically there appears to be relatively more 17∶0 and 24∶1 and less 16∶1 and 18∶1 than in plasma membrane phospholipids of undifferentiated L6 myoblasts. These observations indicate that significant changes in plasma membrane lipid composition occur during myoblast differentiation. The role that changes in lipid composition play in control of cellular differentiation, however, remains to be elucidated.
Gene Expression Profiling on Lung Cancer Outcome Prediction: Present Clinical Value and Future Premise
Sun, Zhifu , Yang, Ping , Sun, Zhifu

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | November 21, 2006 | Volume: 15 | Issue: 11 | Pages: 2063-2068

10.1158/1055-9965.epi-06-0505 | PMID 17119029 Get It

Abstract DNA microarray has been widely used in cancer research to better predict clinical outcomes and potentially improve patient management. The new approach provides accurate tumor classification and outcome predictions, such as tumor stage, metastatic status, and patient survival, and offers some hope for individualized medicine. However, growing evidence suggests that gene-based prediction is not stable and little is known about the prediction power of gene expression profiles compared with well-known clinical and pathologic predictors. This review summarized up-to-date publications in microarray-based lung cancer clinical outcome prediction and conducted secondary analyses for those with sufficient sample sizes and associated clinical information. Among the most commonly used analytic approaches, unsupervised clustering mainly recaptures tumor histology and provides variable degrees of prediction for tumor stage, lymph node status, or survival. Overall, most studies lack an independent validation. Supervised learning and testing generally offer a better prediction. Noted is that when conventional predictors of age, gender, stage, cell type, and tumor grade are considered collectively, the predictive advantage of the gene expression profiles diminishes. We conclude that outcome prediction from gene expression signatures selected by current analytic approaches can be mostly explained by well-known conventional predictors, particularly histologic subtype and grade of differentiation. A strategy for establishing independent or more accurate signatures is commented. (Cancer Epidemiol Biomarkers Prev 2006;15(11):2063–8)
Methylenetetrahydrofolate Reductase Haplotype Tag Single-Nucleotide Polymorphisms and Risk of Breast Cancer
Martin, Yvette N. , Vierkant, Robert A. , Fredericksen, Zachary S., Wu, Yanhong , Schaid, Daniel J. , Sellers, Thomas A. , Weinshilboum, Richard M. , Olson, Janet E. , Ingle, James N. , Pankratz, V. Shane , Weinshilboum, Richard M. , Vierkant, Robert A

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | November 21, 2006 | Volume: 15 | Issue: 11 | Pages: 2322-2324

10.1158/1055-9965.epi-06-0318 | PMID 17119067 Get It

Decreased NKX3.1 Protein Expression in Focal Prostatic Atrophy, Prostatic Intraepithelial Neoplasia, and Adenocarcinoma: Association with Gleason Score and Chromosome 8p Deletion
Bethel, Carlise R., Faith, Dennis, Li, Xiang, Guan, Bin , Hicks, Jessica , Lan, Fusheng, Jenkins, Robert B. , Bieberich, Charles J. , Li, Xiang, Lan, Fusheng, Marzo, Angelo M. De

Mayo Clinic

Cancer Research | November 15, 2006 | Volume: 66 | Issue: 22 | Pages: 10683-10690

10.1158/0008-5472.can-06-0963 | PMID 17108105 Get It

Abstract NKX3.1 is a homeobox gene located at chromosome 8p21.2, and one copy is frequently deleted in prostate carcinoma. Prior studies of NKX3.1 mRNA and protein in human prostate cancer and prostatic intraepithelial neoplasia (PIN) have been conflicting, and expression in focal prostate atrophy lesions has not been investigated. Immunohistochemical staining for NKX3.1 on human tissue microarrays was decreased in most focal atrophy and PIN lesions. In carcinoma, staining was inversely correlated with Gleason grade. Fluorescence in situ hybridization showed that no cases of atrophy had loss or gain of 8p, 8 centromere, or 8q24 (C-MYC) and only 12% of high-grade PIN lesions harbored loss of 8p. By contrast, NKX3.1 staining in carcinoma was correlated with 8p loss and allelic loss was inversely related to Gleason pattern. Quantitative reverse transcription-PCR for NKX3.1 mRNA using microdissected atrophy revealed a concordance with protein in five of seven cases. In carcinoma, mRNA levels were decreased in 6 of 12 cases but mRNA levels correlated with protein levels in only 4 of 12 cases, indicating translational or post-translational control. In summary, NKX3.1 protein is reduced in focal atrophy and PIN but is not related to 8p allelic loss in these lesions. Therefore, whereas genetic disruption of NKX3.1 in mice leads to PIN, nongenetic mechanisms reduce NKX3.1 protein levels early in human prostate carcinogenesis, which may facilitate both proliferation and DNA damage in atrophic and PIN cells. Monoallelic deletions on chromosome 8p are associated with more advanced invasive and aggressive disease. (Cancer Res 2006; 66(22): 10683-90)